CN Patent

CN112135812A — 氯胺酮衍生物及其药物组合物

Assigned to XWPharma Ltd · Expires 2020-12-25 · 5y expired

What this patent protects

公开了氯胺酮衍生物及其药物组合物。当口服施用时，氯胺酮衍生物在体循环中提供增加的氯胺酮生物利用度。氯胺酮衍生物可用于治疗神经疾病、精神疾病和疼痛。

USPTO Abstract

公开了氯胺酮衍生物及其药物组合物。当口服施用时，氯胺酮衍生物在体循环中提供增加的氯胺酮生物利用度。氯胺酮衍生物可用于治疗神经疾病、精神疾病和疼痛。

Drugs covered by this patent

Patent Metadata

Patent number
CN112135812A
Jurisdiction
CN
Classification
—
Expires
2020-12-25
Drug substance claim
No
Drug product claim
No
Assignee
XWPharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.